Skip to main content

Lite Strategy, Inc.

LITS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001262104

No open-market purchases or sales by Lite Strategy, Inc. insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $5.43M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Lite Strategy, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of LITS: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders4929−20
SharesConverted for a 1-for-20 split2.44M2.43M−11.8K (−0.5%)
Value$11.2M$16.0M+$4.81M (+43.0%)

New holders (5)

Institutions that held Lite Strategy, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to LITS in Q2 2023
InstitutionSharesValue% of portfolio
BML Capital Management, LLC22,966$151.1K0.14%
Susquehanna International Group, LLP10,791$71.0K0.00%
Bridgeway Capital Management, LLC10,600$69.7K0.00%
Simplex Trading, LLC4,326$28.0K0.00%
Rhumbline Advisers122$8020.00%

Sold out (25)

Institutions that held Lite Strategy, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.